Ticker Details
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
IPO Date:	July 6, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.27B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 3.22%
Avg Daily Range (30 D):	$1.29 | 2.17%
Avg Daily Range (90 D):	$1.52 | 2.42%

Institutional Daily Volume
Avg Daily Volume:	.79M
Avg Daily Volume (30 D):	1.81M
Avg Daily Volume (90 D):	2.17M

Trade Size
Avg Trade Size (Sh.):	110
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	5,942
Avg Institutional Trade:	$3.77M
Avg Institutional Trade (30 D):	$5.71M
Avg Institutional Trade (90 D):	$7.41M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$6.35M
Avg Closing Trade (30 D):	$21.81M
Avg Closing Trade (90 D):	$23.96M
Avg Closing Volume:	191.13K

News

Feb 13, 2026 @ 6:45 PM CRISPR Therapeutics Spotlights Momentum For Lead G... Source: Vandana Singh

Feb 9, 2026 @ 6:00 PM Idiopathic Pulmonary Fibrosis Clinical Trials & Pi... Source: Delveinsight

Jan 6, 2026 @ 3:32 PM Arrowhead Obesity Drugs Show Significant Fat Loss ... Source: Vandana Singh

Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight

Apr 4, 2024 @ 11:23 AM NetApp, Zoom Video And 2 Other Stocks Insiders Are... Source: Avi Kapoor

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.56	$.22	$-.18
Diluted EPS	$1.53	$.22	$-.18
Revenue	$1.09B	$264.03M	$256.47M
Gross Profit
Net Income / Loss	$233.57M	$28.24M	$16.12M
Operating Income / Loss	$300.57M	$40.81M	$44.11M
Cost of Revenue
Net Cash Flow	$147.75M	$-24.91M	$96.76M
PE Ratio	42.48

Splits
Nov 17, 2011	1:10
Jan 15, 2004	1:65